Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / CYAD - Celyad: Assessing This CAR-T Concern


CYAD - Celyad: Assessing This CAR-T Concern

Some people fight fire with fire. I've found water to be more effective.” - Adrianne Ambrose

Today, we go across the pond to take a look at Celyad (CYAD). This company is a small CAR-T focused ‘Tier 4’ developmental concern that is targeting multiple indications. A full analysis of this interesting and bit of an 'off the radar' name is provided in the paragraphs below.

Company Overview:

Celyad is a Mont-Saint-Guibert, Belgium-based clinical-stage biopharmaceutical company that is focused on reversing the outcomes of severe diseases. Celyad’s ordinary shares are listed on

Read more ...

Stock Information

Company Name: Celyad SA
Stock Symbol: CYAD
Market: NASDAQ

Menu

CYAD CYAD Quote CYAD Short CYAD News CYAD Articles CYAD Message Board
Get CYAD Alerts

News, Short Squeeze, Breakout and More Instantly...